M&A Deal Sparks Sharp Moves in KVUE

3 months ago

Critty Gupta

"Kimberly Clark. To your point, uh KMBB is your ticker for Kimberly Clark. Ken View, the maker of Tylenol, which is the spin-off of Johnson and Johnson. KV KVUE is the ticker there. Shares jump in. Get this, Nathan. 35% in the pre-market after Kimberly Carr agreed to buy the consumer health company. This isn't even a rumor. This is happening. Uh in a cash and stock deal that's really valuing the company at about 48.7 billion. The classic M&A arbitrage, you are seeing Kimberly Clark shares KMBB uh slump by as much as 16% in the pre-market."

The segment details an M&A deal where Kimberly Clark is acquiring a consumer health business, triggering a 35% pre-market surge for KVUE after the deal announcement. The commentary highlights the dramatic market impact including a significant pre-market move and a cash and stock transaction valuing the deal at approximately $48.7 billion.

Related Stocks